Determination of Left Ventricular Ejection Fraction Using Cardiac Angioscintigraphy
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT02869308
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 100 participants
- Registry
-
NCT02869308
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Unknown status
Technical summary
Registry record NCT02869308. Allocation not applicable; no masking; primary purpose diagnostic. Start 2014-01 (registry gives no type); primary completion 2018-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Determination of Left Ventricular Ejection Fraction Using Cardiac Angioscintigraphy
- Acronym
- FEVED
- Condition
- Angioscintigraphy
- Condition
- Tomoscintigraphy
- Intervention (Drug)
- stannous pyrophosphate
- Intervention (Drug)
- Technetium-99m
- Intervention (Device)
- E-CAM Camera
- Intervention (Device)
- CZT Semiconductor Camera (D-SPECT)
- Lead sponsor
- Central Hospital, Nancy, France
Record details
- Record id
cardio:ct-nct02869308- Content hash
adf45cf2abff62683816699790223659dfadae482c964eedca670bf24f4155bb